Cargando…
GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers
Altered A-to-I RNA editing has been widely observed in many human cancers and some editing sites are associated with drug sensitivity, implicating its therapeutic potential. Increasing evidence has demonstrated that a quantitative trait loci mapping approach is effective to understanding the genetic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728115/ https://www.ncbi.nlm.nih.gov/pubmed/34534336 http://dx.doi.org/10.1093/nar/gkab810 |